HIV Infection: An Update on Antiretroviral Therapy- Pharmacist

  Price  

  Credits  2.5

This product is currently out of stock and unavailable.


Format
Twenty five years after the first case of AIDS was reported, the HIV epidemic remains at global proportions. The number of new HIV infections in the U.S. appears to have stabilized at about 55, 000 cases per year. Although this is a big increase over previous estimates, it results from improved reporting rather than an actual increase in new cases. A “cure” for HIV or an effective vaccine is unlikely to be introduced in the next few decades. Vaccine trials have been stopped due to higher rates of HIV infection among those vaccinated. There are currently 23 approved anti-HIV agents among 6 classes. The newer drugs may improve adherence because of improved tolerability. New agents also allow most patients who have failed several drug regimens to achieve viral suppression similar to that of patients who are on their first anti-HIV drug regimen. This issue reviews the 6 classes of anti-HIV drugs and the current recommendations for first-line treatment of HIV infection. Recently discovered life-threatening adverse effects of individual agents and long-term HAART are discussed. Easy-to-use tables provide detailed information on appropriate doses, administration strategies, side effects, and key drug interactions to help you effectively participate in drug therapy management. In the Rx Patient Connection, you’ll find the answers to commonly asked questions about HIV medications, including why “drug holidays” are no longer considered a good idea.

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 428-0000-08-010-H02-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.